Clinical outcomes of COVID-19 treated with remdesivir across the continuum of care.

Christina G RiveraSupavit ChesdachaiEvan W DraperRichard F ArndtKristin C MaraMaria Gonzalez SuarezRaymund R Razonable

Published in: Influenza and other respiratory viruses (2023)

This study describes the clinical outcomes of a strategy of transitioning remdesivir therapy from inpatient to outpatient among selected patients. Mortality was lower among patients who completed the 5-day course of remdesivir.

Keyphrases

end stage renal disease
newly diagnosed
palliative care
coronavirus disease
chronic kidney disease
sars cov
healthcare
peritoneal dialysis
prognostic factors
cardiovascular events
mental health
coronary artery disease
pain management
patient reported
smoking cessation